A government panel in Taiwan has decided that the anti bird flu drug Tamiflu can be produced there without permission from the Swiss drug maker Roche AG, if supplies of the medicine run out.According to the Intellectual Property Office the prod
Indonesian President Susilo Bambang Yudhoyono says the authorities there will cooperate with the U.S.-based Baxter International to produce human vaccines for the H5N1 bird flu virus.President Yudhoyono says that Baxter has offered the option o
Major drug company GlaxoSmithKline is hoping to develop an experimental AIDS vaccine by "piggy-backing" on a shot against measles.A collaboration between Europe's biggest drug maker and France's
Drug giant Roche, the makers of the anti-viral drug Tamiflu, say that both Thailand and the Philippines are free to begin making their own versions of the drug.The medication which governments a
Health Canada along with drug company Novartis Pharmaceuticals Canada, have issued a warning concerning the drug Femara (letrozole), which is used t
Bentley Pharmaceuticals, Inc. (AMEX: BNT), a specialty pharmaceutical company focused on advanced drug-delivery technologies, which also manufactures and markets generic an
A new anthrax antibody engineered by scientists at The University of Texas at Austin protects and defends against inhalation anthrax without the use of antibiotics and other more expensive antibodies.
New research into the cost of using the breast cancer drug Herceptin warns that healthcare authorities and the organisations advising them should not rush to prescribe it for early breast cancer without working out extremely carefully the budget implic
Decision Resources, Inc., a research and advisory firms focusing on pharmaceutical and health care issues, finds that restrictions by health insurers and government health authorities to cont
Pharmaceutical companies spend more to support a cardiovascular compound's development and commercialization than other therapeutic products, according to research conducted by Cutting Edge Information (
"This action today is yet another indication of the Department of Health and Human Services' and the FDA's deep commitment to the President's Emergency Plan by helping to ensure that the products offered to patients under this plan are indeed safe, effective, quality medications," said Murray M. Lumpkin, M.D., Acting Deputy Commissioner for International and Special Programs.
The Emergency Plan for AIDS Relief, which President Bush first announced in his 2003 State of the Union Address, is currently providing $15 billion to fight the HIV/AIDS pandemic over five years, with a special focus on 15 of the hardest hit countries. It targets three specific areas related to HIV/AIDS:
Prevention of HIV transmission; Treatment of AIDS and associated conditions; Care, including palliative care for HIV infected-individuals, and care for orphans and vulnerable children.Lamivudine is in the class of drugs called Nucleoside Reverse Transcriptase Inhibitors (NRTIs), which stop the HIV from infecting uninfected cells in the body. This antiretroviral drug is used in combination with other antiretroviral agents for the treatment of HIV-1 infection.
This is the second application for Lamivudine Tablets for which FDA has granted tentative approval.
The agency's tentative approval means that although existing patents and/or exclusivity prevent U.S. marketing of Aurobindo's product, it meets FDA's quality, safety and efficacy standards for U.S. marketing.
http://www.fda.gov